ELECTROPHORESIS ABNORMAL

ELECTROPHORESIS ABNORMAL was reported 24 times

ELECTROPHORESIS ABNORMAL is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 CD38-directed Cytolytic Antibody [EPC] 1 0.0002
1 Lipid-based Polyene Antifungal [EPC] 2 0.0002
2 Tissue-nonspecific Alkaline Phosphatase [EPC] 1 0.0001
3 Polyene Antifungal [EPC] 2 0.0000
4 PCSK9 Inhibitor [EPC] 1 0.0000
5 Integrin Receptor Antagonist [EPC] 2 0.0000
6 Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] 1 0.0000
7 Proteasome Inhibitor [EPC] 2 0.0000
8 Glycopeptide Antibacterial [EPC] 1 0.0000
9 Nitroimidazole Antimicrobial [EPC] 1 0.0000
10 Tetracycline-class Drug [EPC] 1 0.0000
11 Purine Antimetabolite [EPC] 1 0.0000
12 Interleukin-23 Antagonist [EPC] 1 0.0000
13 Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] 1 0.0000
14 Calcineurin Inhibitor Immunosuppressant [EPC] 1 0.0000
15 Vitamin D [EPC] 2 0.0000
16 Azole Antifungal [EPC] 1 0.0000
17 Janus Kinase Inhibitor [EPC] 1 0.0000
18 Vitamin B12 [EPC] 2 0.0000
19 Expectorant [EPC] 1 0.0000
20 Thiazide Diuretic [EPC] 1 0.0000
21 Vitamin C [EPC] 2 0.0000
22 Anti-epileptic Agent [EPC] 1 0.0000
23 Corticosteroid [EPC] 5 0.0000
24 Thalidomide Analog [EPC] 2 0.0000
25 Factor Xa Inhibitor [EPC] 1 0.0000
26 HMG-CoA Reductase Inhibitor [EPC] 1 0.0000
27 Kinase Inhibitor [EPC] 1 0.0000
28 Platelet Aggregation Inhibitor [EPC] 1 0.0000
29 Benzodiazepine [EPC] 1 0.0000
30 Tumor Necrosis Factor Blocker [EPC] 1 0.0000
31 Nonsteroidal Anti-inflammatory Drug [EPC] 1 0.0000